SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-006697
Filing Date
2016-08-11
Accepted
2016-08-11 16:33:34
Documents
56
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q s103868_10q.htm 10-Q 314917
2 EXHIBIT 31-1 s103868_ex31-1.htm EX-31.1 7157
3 EXHIBIT 31-2 s103868_ex31-2.htm EX-31.2 7093
4 EXHIBIT 32-1 s103868_ex32-1.htm EX-32.1 4037
5 EXHIBIT 32-2 s103868_ex32-2.htm EX-32.2 4191
  Complete submission text file 0001615774-16-006697.txt   2699899

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE avxl-20160630.xml EX-101.INS 500692
7 XBRL SCHEMA FILE avxl-20160630.xsd EX-101.SCH 35289
8 XBRL CALCULATION FILE avxl-20160630_cal.xml EX-101.CAL 38063
9 XBRL DEFINITION FILE avxl-20160630_def.xml EX-101.DEF 148513
10 XBRL LABEL FILE avxl-20160630_lab.xml EX-101.LAB 263157
11 XBRL PRESENTATION FILE avxl-20160630_pre.xml EX-101.PRE 208130
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 161825022
SIC: 8731 Services-Commercial Physical & Biological Research